세계의 감염 예방 및 관리 시장 규모는 2024년-2030년의 예측기간 동안 복합 연간 성장률(CAGR) 6.13%의 대폭적인 성장이 전망되고 있습니다. 감염 예방 및 관리 수요는 주로 만성질환의 유병률 증가, 고강도 감염 예방을 필요로 하는 외과 수술 증가, 원내 감염 증가, 고도의 감염 예방을 확보하는 정부의 대처 증가, 의료 산업의 성장, 제품의 발매 증가, 제품 개발에 있어서의 기술 혁신 등에 의해 뒷받침되고 있어 그에 의해 2024년-2030년의 예측기간 동안 감염 예방 및 관리 시장 전체의 성장에 기여하고 있습니다.
감염 예방 및 관리 시장 역학
전 세계의 원내 감염의 유행은 예측 기간의 원내 감염 방지 시장을 강화할 것으로 예측됩니다.
예를 들어, 세계보건기구(WHO)(2022)에 따르면 전 세계적으로 매년 수억 명의 사람들이 의료 관련 감염(HAI)의 영향을 받고 있으며, 대부분은 완전히 회피가능하다고 추정됩니다.
이 자료에 따르면 100명의 환자 중 7명이 고소득 국가에, 15명이 중저소득 국가에 있다고 합니다. WHO는 또한 전 세계적으로 이환된 환자 중 10명 중 1명이 원내 감염으로 사망하고 있다고 결론 내렸습니다.
이상의 수치로부터, 원내 감염의 유병률은 세계에서 증가하고 있다고 결론지을 수 있습니다. 감염으로 인한 유병률과 사망률 증가는 적절한 손가락 위생 유지, 마스크 및 장갑과 같은 보호 장비의 착용, 오염된 장소의 소독, 병원에서 사용되는 모든 장비의 적절한 멸균 등 적절한 조치로 억제할 수 있습니다. 따라서 위의 요인이 예측기간 동안 감염 예방 및 관리의 전체적인 시장 성장의 요인이 됩니다.
염증성 장질환(IBD), 위식도 역류증(GERD), 소화성 궤양 질환, 크론병, 당뇨병, 고혈압, 심혈관 장애, 암 등의 환경 오염과 흡연, 건강에 해로운 생활 습관, 영양과 음식 생활의 혼란, 발암성 물질의 다량 섭취에 의한 만성 질환의 유병률의 상승은 감염 예방 및 관리의 제품이나 기기 시장을 견인합니다.
예를 들어 International Diabetes Federation의 Diabetes Atlas 10판 보고서(2021)에 따르면 2021년에 전 세계의 5억 3, 700만 명의 성인(20-79세)이 당뇨병을 앓고 있습니다. 이 수치는 2030년까지 6억 4, 300만 명, 2045년까지 7억 8, 300만 명으로 증가할 것으로 예측됩니다. 만성 질환의 유병률이 높아짐에 따라 외과 수술의 건수도 증가하고 감염증의 위험도 높아집니다. 감염은 적절한 멸균 및 소독 기술을 따르며 손가락이나 표면의 소독제, 장갑, 마스크 등 다양한 감염 예방 및 대책 제품을 사용하여 막을 수 있습니다.
그러므로 만성질환의 유병률 상승으로 인한 외과 수술의 건수 증가는 원내 감염의 유병률을 증가시킬 수 있어, 결과적으로 감염 예방 및 관리 제품 수요를 증가시킵니다.
게다가 정부기관은 효과적인 예방책에 대한 세계의 인식을 높이는 것을 목적으로 하는 가이드라인의 발행에 적극적으로 되어 있기 때문에 예측기간을 통해 시장 성장에 있어 큰 역할을 할 전망입니다. 예를 들어, 세계보건기구(WHO)는 유행병 및 전염병을 앓고 있는 급성 호흡기 질환의 예방과 관리에 관한 의료 산업 가이드라인을 발표하고 있습니다. 그 권장 사항은 자주 화장실과 같은 상식적인 안전 대책에서 개인보호구(PPE) 사용, 멸균 및 소독 지침까지 다양합니다.
따라서 위의 요인이 2024년-2030년의 예측기간 동안 감염 예방 및 관리 시장을 추진합니다.
그러나 화학소독제의 악영향이나 재처리된 기구의 안전성을 우려하는 엄격한 규제 요건 등이 감염 예방 및 관리 시장 전체의 성장을 억제할 가능성이 있습니다.
감염 예방 및 대책 시장의 부문 분석
감염 예방 및 관리 시장의 제품 유형 부문에서는 손가락 소독제 카테고리가 2023년에 큰 수익 점유율을 획득할 전망입니다. 이는 이 부문와 관련된 이점과 용도로 인한 것으로 간주됩니다.
손가락 소독제는 표면에 존재하는 박테리아와 바이러스를 약간의 시간에 사멸시킵니다. 또한 손가락 소독제는 일반적으로 비독성이며 자극이 없으며 저렴하고 비 알레르기성입니다.
본 보고서에서는 세계의 감염 예방 및 관리 시장에 대해 조사 분석하여 시장 규모와 예측, 촉진요인과 과제, 기업과 제품프로파일 등의 정보를 제공합니다.
Infection Prevention And Control Market By Product (Equipment [Sterilization Equipment {Heat Sterilization Equipment, Low-Temperature Sterilization Equipment, Radiation Sterilization, And Others} And Disinfectors {Washers, Flushes, Endoscope Reprocessors, And Others}] And Consumables [Disinfectants {Hand Disinfectants, Surface Disinfectants, Skin Disinfectants, And Others}, Personal Protective Equipment {Surgical Drapes, Surgical Gowns, Gloves, And Others}, Sterilization Consumables, Infectious Waste Disposal, And Others]), End-User (Hospitals & Clinics, Medical Device And Pharmaceutical Companies, And Others), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of hospital-acquired infection and growing number of surgical procedures that require high-intensity infection prevention
The global infection prevention and control market is poised for significant growth, projected to achieve a remarkable Compound Annual Growth Rate (CAGR) of 6.13% during the forecast period from 2024 to 2030. The demand for infection prevention and control is primarily being boosted by the increasing prevalence of increasing incidence of chronic diseases, the growing number of surgical procedures that require high-intensity infection prevention, growing figures of hospital-acquired infections, the rising number of government initiatives to ensure a high degree of infection prevention, growing healthcare industry, increasing product launches, and innovation in product development among others, thereby contribute to the overall growth of the infection prevention and control market during the forecast period from 2024-2030.
Infection Prevention And Control Market Dynamics:
The increasing prevalence of hospital-acquired infection globally is anticipated to bolster the market for hospital-acquired infection control during the forecasted period.
For instance, according to the World Health Organization (WHO) 2022, it was estimated that globally hundreds of millions of people every year are affected by healthcare-associated infections (HAIs), many of which are completely avoidable.
As per the same source, it was reported that out of every 100 patients, 7 patients are in high- and 15 patients in low or middle-income countries. WHO also concluded that globally, 1 in every 10 affected patients dies of a hospital-acquired infection.
From the above figures, it can be concluded that the prevalence of hospital-acquired infection is increasing globally. The increasing prevalence and mortality from the infection can be controlled by following proper measures such as maintaining proper hand hygiene, wearing masks, gloves, and other protective gear, disinfecting the area subjected to contamination, and following proper sterilization of all the equipment used in the hospitals; thereby increasing the demand of infection prevention and control products across the globe. Thus, the above factor will be responsible in propelling the overall market growth of infection prevention and control during the forecast period.
The rise in prevalence of chronic diseases like inflammatory bowel disease (IBD), gastroesophageal reflux disease (GERD), peptic ulcer disease, Crohn's disease, diabetes, hypertension, cardiovascular disorders, cancer, and others due to environmental pollution, smoking, unhealthy lifestyles, poor nutrition and diet, and high intake of carcinogenic substances will drive the market of infection prevention and control product and devices.
For instance, according to the International Diabetes Federation, Diabetes Atlas 10th edition report 2021, globally 537 million adults (20-79 years) were living with diabetes in 2021. This number is predicted to rise to 643 million by 2030 and 783 million by 2045. The rising prevalence of chronic disease will also increase the number of surgical procedures which in turn will increase the risk of infections. The transition of infections can be ceased by following proper sterilization and disinfectant techniques and also by using various infection prevention and control products such as hand or surface disinfectant, gloves, masks, and others.
Therefore, the rising number of surgical procedures owing to the rising prevalence of chronic disorders may increase the prevalence of hospital-acquired infections ultimately increasing the demand for infection prevention and control products.
In addition, government agencies are likely to play a larger role in the market's growth throughout the forecast period as they become more active in the issuance of guidelines aimed at raising global awareness of effective preventive measures. For example, the World Health Organization (WHO) has published guidelines for the healthcare industry's prevention and management of acute respiratory disorders that are susceptible to pandemics and epidemics. The recommendations cover anything from common sense safety measures like washing your hands often to using personal protective equipment and instructions for sterilizing and disinfecting.
Therefore, the above-mentioned factors will propel the infection prevention and control market during the forecast period from 2024-2030.
However, adverse effects of chemical disinfectants, stringent regulatory requirements with concerns for the safety of reprocessed instruments, and others may restrict the growth of the overall infection prevention and control market.
Infection Prevention And Control Market Segment Analysis:
Infection Prevention and Control Market by Product (Equipment [Sterilization Equipment {Heat Sterilization Equipment, Low-Temperature Sterilization Equipment, Radiation Sterilization, and Others} and Disinfectors {Washers, Flushes, Endoscope Reprocessors, and Others}] and Consumables [Disinfectants {Hand Disinfectants, Surface Disinfectants, Skin Disinfectants, and Others}, Personal Protective Equipment {Surgical Drapes, Surgical Gowns, Gloves, and Others}, Sterilization Consumables, Infectious Waste Disposal, and Others]), End-User (Hospitals & Clinics, Medical Device And Pharmaceutical Companies, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product type segment of the infection prevention and control market, the hand disinfectants category is expected to amass a significant revenue share in the year 2023. This can be ascribed to the advantages and applications associated with the segment.
Hand disinfectants take very little time to kill the bacteria or viruses present on any surface. Additionally, hand disinfectants are generally nontoxic, non-irritating, inexpensive, and non-allergenic.
Hand disinfectants are easily portable therefore they can be used anywhere. It not only kills germs but prevents the transmission of germs from one person to another.
Further, alcohol-based hand disinfectants effectively reduce the bacterial counts on hands better than soap and water. Alcohol-based hand disinfectants are more effective against most bacteria and many viruses than either medicated or non-medicated soaps.
In addition, the usage of hand disinfectants was higher in hospitals during the pandemic as the number of hospitalizations increased during this time. The prime aim of hand disinfectants was to provide protection in healthcare facilities and safeguard personnel performing medical procedures that expose them to the virus.
Moreover, the product launches in the local market, in turn, drive the product demand in the market. For instance, in May 2020, Dukes India launched hand sanitizers, a type of hand disinfectant named Hand Safe, to help combat the COVID-19 virus.
Also, in June 2020, Cadila Pharmaceuticals launched a range of hand sanitizers, under the brand name Santiza and Laglo.
Therefore, owing to the above-mentioned factors, the hand disinfectants category is expected to register significant growth, thereby driving the growth of the overall infection prevention and control market during the forecast period.
North America is expected to dominate the overall Infection Prevention And Control Market:
Among all the regions, North America is estimated to account for the largest share of the infection prevention and control market in the year 2023. Owing to the significance of key growth factors such as the growing incidence of chronic diseases such as cancer, kidney disease, Crohn's disease, growing incidence of hospital-acquired infections and the high geriatric population, and high awareness about the advantages of proper infection prevention and control, consistent number of strategic collaborations, growing presence of outsourcing organizations, growing healthcare expenditure, unprecedented evolution of the healthcare standards and infrastructure, and others, the market for infection prevention and control is expected to witness prosperity in the region during the forecast period 2024-2030.
According to the Centers for Disease Control and Prevention (CDC), 2020 Annual National and State Healthcare-Associated Infections (HAI) Progress Report, it was estimated that between 2019 and 2020 in the United States, about 24% increase seen in central line-associated bloodstream infections (CLABSI) with the largest increase in infections transmitted from ICU.
The increasing prevalence of hospital-acquired infections will in turn increase the demand for infection prevention and control devices and consumables in the United States.
Further, a consistent number of strategic collaborations adopted by key market players to widen their product portfolio and infection control capabilities are believed to be responsible for the greater share captured by this region. For instance, In March 2023, Getinge completed the acquisition of Ultra Clean Systems Inc., a leading US manufacturer of ultrasonic cleaning technologies, used in hospitals and surgery centers to decontaminate surgical instruments. Ultrasonic cleaning is an integral part of best practices for reprocessing instruments, especially the most complex ones used for robotic surgery, to minimize the risk of hospital-acquired infections
Also, in March 2019, Getinge announced the US launch of a new 9100E Cart Washer. The 9100E Cart Washer represents the evolution of the company's successful 9100 series floor-loading cart and utensil washer-disinfectors. It was specifically designed to address the needs of hospitals, which require washers that have a reliable and sufficient throughput of a large variety of items that cannot be disinfected in a traditional instrument washer-disinfector, such as operating table transport trolleys, instrument containers, and other bulky items.
Thus, the above-mentioned factors are likely to propel the growth of the infection prevention and control market in the region during the forecast period from 2024-2030.
Infection Prevention And Control Market Key Players:
Some of the key market players operating in the infection prevention and control market include 3M, Fortive, Medivators Inc., Getinge AB, MELAG Medizintechnik GmbH & Co. KG, Metrex Research, LLC, MMM Group, STERIS, Sotera Health LLC, Nanosonics, BD, Owens & Minor, Matachana Group, Xenex Disinfection Services Inc., Ecolab, Bombayengg, Pal International, BIONICS SCIENTIFIC TECHNOLOGIES (P) LTD., Miele Group, Belimed AG, and others.
Recent Developmental Activities in the Infection Prevention And Control Market:
Key Takeaways from the Infection Prevention And Control Market Report Study
Target Audience who can be benefited from this Infection Prevention And Control Market Report Study
Frequently Asked Questions for the Infection Prevention And Control Market:
Infection control products are concerned with the prevention or control of infection in healthcare settings, such as laboratories, hospitals, and others.
The global infection prevention and control market is poised for significant growth, projected to achieve a remarkable Compound Annual Growth Rate (CAGR) of 6.13% during the forecast period from 2024 to 2030.
The demand for infection prevention and control is primarily being boosted by the increasing incidence of hospital-acquired infections, the growing number of surgical procedures that require high-intensity infection prevention, the increasing incidence of chronic diseases along with the increasing geriatric population, increasing product launches, and others thereby contributing to the overall growth of the infection prevention and control market during the forecast period from 2024-2030.
Some of the key market players operating in the infection prevention and control market include 3M, Fortive, Medivators Inc., Getinge AB, MELAG Medizintechnik GmbH & Co. KG, Metrex Research, LLC, MMM Group, STERIS, Sotera Health LLC, Nanosonics, BD, Owens & Minor, Matachana Group, Xenex Disinfection Services Inc., Ecolab, Bombayengg, Pal International, BIONICS SCIENTIFIC TECHNOLOGIES (P) LTD., Miele Group, Belimed AG, and others.
North America is expected to dominate the overall infection prevention and control market during the forecast period from 2024-2030. Owing to factors such as the growing incidence of chronic diseases such as cancer, kidney disease, and Crohn's disease, the growing incidence of hospital-acquired infections and the high geriatric population, and high awareness about the advantages of proper infection prevention and control, a consistent number of strategic collaborations, growing presence of outsourcing organizations, growing healthcare expenditure, and unprecedented evolution of the healthcare standards and infrastructure, among others, the North America infection prevention and control market is expected to growth in coming years.